The largest database of trusted experimental protocols

D luciferin solution

Manufactured by GoldBio
Sourced in Macao, United States, Sao Tome and Principe, China

D-luciferin solution is a laboratory reagent used in bioluminescence assays. It serves as a substrate for the luciferase enzyme, enabling the production of light. The solution is provided in a concentrated form for dilution and use in various experimental applications.

Automatically generated - may contain errors

11 protocols using d luciferin solution

1

Monitoring hSC-β Cell Survival In Vivo

Check if the same lab product or an alternative is used in the 5 most similar protocols
Nanoporous immunoprotective devices encapsulated with luciferase-expressing human embryonic cell-derived pancreatic β-like cell clusters (hSC-βC) were implanted between the caudate and left hepatic lobes of the liver of NOD.Cg-Prkdcscid IIl2rgtm1Wjl/SxJ (NSG) mice. Survival of the encapsulated cells in vivo was assessed by monitoring luciferase activity using a Xenogene IVIS 200 imaging system (PerkinElmer). The animals transplanted with hSC-βC cells were injected IP with d-luciferin solution (Goldbio, St. Louis, MO) at the dose of 150 mg/kg 5 min before imaging to capture the peak in bioluminescent intensity. The mice were anesthetized with an isoflurane mixture (2% in 98% O2) and imaged using a Xenogen IVIS 200 imaging system. Bioluminescence images were acquired for 3 min and then analyzed using the Living Image analysis software (Xenogen, Alameda, CA). Regions of interest (ROI) were centered over the bioluminescence regions. Photons were counted within the ROI over the acquisition time. Adherence to the same imaging protocol ensured consistent signal detection on different days of in vivo imaging.
+ Open protocol
+ Expand
2

Bioluminescence Imaging of Tumor Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
We injected 100 µl of d-luciferin solution (10 mg/ml in PBS, i.v.; GoldBio) into anesthetized tumor-bearing mice. Bioluminescence from the luciferase-expressing tumor cells was determined using IVIS-SPECTRUM in vivo photon-counting device (Caliper Life Sciences). Images were quantified as photon counts/second using the Living Image software (Caliper Life Sciences).
+ Open protocol
+ Expand
3

In Vivo Bioluminescent Imaging of Mice

Check if the same lab product or an alternative is used in the 5 most similar protocols
At the end of miR-106a agomir or NC treatment, mice were injected with 100 μL of the D-luciferin solution (150 mg/kg) (Gold Biotechnology, St. Louis, MO) intraperitoneally (i.p.) 10 min before imaging. During image acquisition, mice were anaesthetized with 50 mg/kg pentobarbital sodium (i.p.) and then imaged using the Xenogen IVIS Spectrum system (Caliper Life Sciences, USA). Signal intensity in both the left and right hind limbs was quantified as photon flux (photons/s/cm2/sr) using the Living Image software 4.2 (Caliper Life Sciences).
+ Open protocol
+ Expand
4

Quantifying Luciferase Expression in BMSCs

Check if the same lab product or an alternative is used in the 5 most similar protocols
To assess the luciferase expression of the transduced BMSCs, different numbers of Luc-GFP-BMSCs (0.1, 0.2, 0.3, 0.4, and 0.5 × 104/well) were seeded into a 96-well plate in 100 μL of growth medium, and D-luciferin solution (D-luciferin, 150 μg/mL, Gold Biotechnology, Inc., USA) was added at room temperature. After 10 min of incubation, the cells were imaged using an in vivo imaging system (IVIS) (PerkinElmer, IVISSPE, USA). The bioluminescent signals were analyzed using Living Image Software 4.5.
+ Open protocol
+ Expand
5

Bioluminescent Imaging of Grafted Mice

Check if the same lab product or an alternative is used in the 5 most similar protocols
Graft‐bearing animals were injected IP with D‐luciferin solution (Goldbio) at 150 mg/kg 30 min before imaging to capture the peak in bioluminescent intensity. Mice were anesthetized with an isoflurane mixture (2% in 98% O2), and the bioluminescent signal was quantified using a Xenogen IVIS 200 imaging system (PerkinElmer). Images were acquired for 1 min and then analyzed using the Living Image analysis software (Xenogen). Regions of interest (ROIs) were centered over the location of the devices, and background signal was obtained by capturing the ROI of a nonbioluminescent signal. Photons collected over the acquisition time were counted within the ROI. The same imaging protocol was applied each time to ensure consistency across longitudinal studies.
+ Open protocol
+ Expand
6

Bioluminescence Imaging of Tumor Xenografts

Check if the same lab product or an alternative is used in the 5 most similar protocols
Mice were inoculated with 5 × 106 luciferase-transfected SPC-A-1 cells and then treated with different drugs for 3 weeks. At the end of treatment, mice were injected (i.p.) with 100 μl of the d-luciferin solution (150 mg/kg) (Gold Biotechnology, St. Louis, MO). During the image acquisition, mice were anesthetized with 50 mg/kg pentobarbital sodium (i.p.) and then imaged in a dorsal position using the Xenogen IVIS Spectrum system (Caliper Life Sciences, USA). Signal intensity in both left and right hind limbs was quantified as photons flux (photons/s/cm2/sr) using Living Image software 4.2 (Caliper Life Sciences) as described previously (Hu et al., 2011 (link)).
+ Open protocol
+ Expand
7

In Vivo Nanoparticle Delivery and Bioluminescence Imaging

Check if the same lab product or an alternative is used in the 5 most similar protocols
All in vivo procedures were approved by the Johns Hopkins University Institutional Animal Care and Use Committee. Balb/c mice (7-week old, female, n = 5 per group, Charles River Laboratories, Frederick, MD) and CD-1 mice (12-week old, female, n = 5 per group, Charles River Laboratories, Frederick, MD) were injected through lateral tail vein with a dose 40 μg DNA of nanoparticles per mouse. pDNA/lPEI nanoparticle formulations (N/P = 6) were prepared as control group for all in vivo experiments according to the manufacturer’s protocol (Polyplus Transfection, France). All the nanoparticle groups were suspended in 9.5% trehalose solution to formulate isotonic for systemic injection. Bioluminescence imaging was performed by using the IVIS® Spectrum (PerkinElmer, Waltham, MA) at 24 h and 48 h time points after nanoparticle injection. Mice were anesthetized with 3% isoflurane and injected i.p. with 100 μL 30 mg/mL D-luciferin solution (Gold Biotechnology, St. Louis. MO). After 5 min injection of D-luciferin, bioluminescence images were obtained; and the images were processed with Living Image Software (PerkinElmer).
+ Open protocol
+ Expand
8

Functional Characterization of KNOX Transcription Factors

Check if the same lab product or an alternative is used in the 5 most similar protocols
The full-length CDS of PINNA1, MtKNOX1, MtKNOX2, MtKNOX6, and MtKNOX7 were PCR amplified and fused to either the pCAMBIA3300-GFP or pCAMBIA3300-GR vector to generate effectors, respectively. The ∼2.9-kb promoter fragment upstream of MtUFO was cloned into the pGreenII-0800-Luc vector to generate a reporter construct. The constructs were introduced into A. tumefaciens GV3101 together with the pSoup19 helper plasmid. At least four tobacco leaves from independent plants were infiltrated and harvested after 48 h. For GR induction, another set of at least four tobacco leaves from independent plants were infiltrated with infiltration buffer containing 10 μM DEX (Coolaber, Cat: SL4070) or an equal volume of ethanol, and harvested after 48 h. The luciferase fluorescence signals were observed by a plant living imaging system (Tanon 5200, China) after these leaves were sprayed with 1 mM d-Luciferin solution (GoldBio, Cat: LUCK-1G) and incubated for 5 min in the dark. Then the rest of the leaves were punched and powdered in liquid nitrogen to measure the LUC and REN activity. Relative LUC and REN activity were measured by the DLR assay system on the Centro XS LB960 (Berthold, Germany). Finally, the relative firefly luciferase activity was calculated as the ratio of LUC to REN for each sample. The primer sequences are listed in Supplementary Data 1.
+ Open protocol
+ Expand
9

Bioluminescence Imaging of Encapsulated Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Thin-film devices with luciferase-expressing MIN6 (MIN6.LUC) cells were implanted, in either the subcutaneous space on the dorsal aspect or the abdominal cavity between the muscle wall and the liver of MOD.Cg-Prkdcscid III2rgtm1Wjl/SxJ (NSG) or BALB/C mice. Persistence of the encapsulated cells in vivo was assessed by monitoring luciferase activity using a Xenogene IVIS 200 imaging system (PerkinElmer). The animals transplanted with MIN6.LUC cells were injected IP with D-luciferin solution (Goldbio, St. Louis, MO) at the dose of 150 mg/kg 8 min before imaging to capture the peak in bioluminescent intensity, as previously described.48 (link) The mice were anesthetized with an isoflurane mixture (2% in 98% O2) and imaged by using a Xenogen IVIS 200 imaging system. Bioluminescence images were acquired for 1 min and then analyzed using the Living Image analysis software (Xenogen, Alameda, CA). Regions of interest (ROI) were centered over the bioluminescence regions. Photons were counted within the ROI over the acquisition time. Adherence to the same imaging protocol ensured consistent signal detection and allowed us to compare data acquired over a period of at least 3 months.
+ Open protocol
+ Expand
10

Luciferase-Expressing hMSC Implantation

Check if the same lab product or an alternative is used in the 5 most similar protocols
WS hMSCs implantation was performed as previously described (Zhang et al., 2015 (link)). In brief, 5 × 105 luciferase-expressing WS hMSCs were pretreated with vehicle or 100 nmol/L Que for 30 days and then implanted into the middle of the tibialis anterior muscle of immunodeficient mice. Five days after the implantation, mice were anaesthetized and injected with D-luciferin solution (Gold-Bio, luck-500). After 15 min the in vivo luciferase activity of each mouse was determined by the IVIS lumina system (PerkinElmer). Luminescence intensity was normalized to luciferase intensity of hMSCs right before the implantation. All the animal experiments performed in this study were approved by the Institute of Biophysics, Chinese Academy of Sciences.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!